Roquefort Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Roquefort Therapeutics has a total shareholder equity of £5.5M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £6.1M and £589.0K respectively.
Key information
0%
Debt to equity ratio
UK£0
Debt
Interest coverage ratio | n/a |
Cash | UK£537.32k |
Equity | UK£5.50m |
Total liabilities | UK£589.03k |
Total assets | UK£6.09m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ROQ's short term assets (£694.9K) exceed its short term liabilities (£307.1K).
Long Term Liabilities: ROQ's short term assets (£694.9K) exceed its long term liabilities (£281.9K).
Debt to Equity History and Analysis
Debt Level: ROQ is debt free.
Reducing Debt: ROQ has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ROQ has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: ROQ has less than a year of cash runway if free cash flow continues to reduce at historical rates of 98.4% each year